. 2019 Oct 14;8(11):1447–1454. doi: 10.1530/EC-19-0429
This work is licensed under a Table 1.
Baseline characteristics of the participants (n = 48).
| Baseline characteristics | n or mean (s.d.) (n = 48)a |
|---|---|
| Men | 21 |
| Age, years | 43.8 (13.8) |
| Race | |
| White | 17 |
| Hispanic white | 19 |
| Black | 7 |
| Asian | 5 |
| BMI, kg/m2 | 24.2 (3.4) |
| Current smoker | 14 |
| Diabetes | 6 |
| Hypertension | 11 |
| Mean SBP/DBP, mmHg | 124/76 (16/10) |
| Cardiovascular disease | 1 |
| Prior fracture | 9a |
| Current use of | |
| Anti-hypertensive | 12 |
| Statins | 7 |
| Folates | 7 |
| Estrogenic contraceptive | 0 |
| Progestogen-only contraceptive | 4 |
| CKD-EPI GFR, mL/min | 107 (17) |
| Hemoglobin, g/L | 138.7 (16.5)b |
| Platelets, G/L | 287.8 (66.1)b |
| Prothrombin time, %c | 92.3 (8.6) |
| aPTT, sc | 30.0 (3.2) |
| Fibrinogen, g/Lc | 3.1 (0.7) |
a1 and b7 missing values; cNormal ranges: Prothrombin time >70%, aPTT 26–37 s, fibrinogen 1.5–3.5 g/L.